208 related articles for article (PubMed ID: 28548944)
1. The adenosine A2b receptor promotes tumor progression of bladder urothelial carcinoma by enhancing MAPK signaling pathway.
Zhou Y; Chu X; Deng F; Tong L; Tong G; Yi Y; Liu J; Tang J; Tang Y; Xia Y; Dai Y
Oncotarget; 2017 Jul; 8(30):48755-48768. PubMed ID: 28548944
[TBL] [Abstract][Full Text] [Related]
2. MRS1754 inhibits proliferation and migration of bladder urothelial carcinoma by regulating mitogen-activated protein kinase pathway.
Zhou Y; Chu X; Yi Y; Hao Z; Zheng X; Yuxin T; Dai Y
J Cell Physiol; 2019 Jul; 234(7):11360-11368. PubMed ID: 30565699
[TBL] [Abstract][Full Text] [Related]
3. Solute carrier family 12 member 5 promotes tumor invasion/metastasis of bladder urothelial carcinoma by enhancing NF-κB/MMP-7 signaling pathway.
Liu JY; Dai YB; Li X; Cao K; Xie D; Tong ZT; Long Z; Xiao H; Chen MK; Ye YL; Liu B; Tan J; Tang J; Xu ZZ; Gan Y; Zhou YH; Deng F; He LY
Cell Death Dis; 2017 Mar; 8(3):e2691. PubMed ID: 28333147
[TBL] [Abstract][Full Text] [Related]
4. T-cell immunoglobulin mucin-3 expression in bladder urothelial carcinoma: Clinicopathologic correlations and association with survival.
Yang M; Yu Q; Liu J; Fu W; Cao Y; Yu L; Shao S; Wang X; Niu H; Wang Y
J Surg Oncol; 2015 Sep; 112(4):430-5. PubMed ID: 26265374
[TBL] [Abstract][Full Text] [Related]
5. High PRMT5 expression is associated with poor overall survival and tumor progression in bladder cancer.
Tan L; Xiao K; Ye Y; Liang H; Chen M; Luo J; Qin Z
Aging (Albany NY); 2020 May; 12(9):8728-8741. PubMed ID: 32392182
[TBL] [Abstract][Full Text] [Related]
6. α4 contributes to bladder urothelial carcinoma cell invasion and/or metastasis via regulation of E-cadherin and is a predictor of outcome in bladder urothelial carcinoma patients.
Liu J; Cai M; Chen J; Liao Y; Mai S; Li Y; Huang X; Liu Y; Zhang J; Kung H; Zeng Y; Zhou F; Xie D
Eur J Cancer; 2014 Mar; 50(4):840-51. PubMed ID: 24388773
[TBL] [Abstract][Full Text] [Related]
7. CD164 promotes tumor progression and predicts the poor prognosis of bladder cancer.
Zhang XG; Zhang T; Li CY; Zhang MH; Chen FM
Cancer Med; 2018 Aug; 7(8):3763-3772. PubMed ID: 30022623
[TBL] [Abstract][Full Text] [Related]
8. Expression and function analysis of indoleamine 2 and 3-dioxygenase in bladder urothelial carcinoma.
Yang C; Zhou Y; Zhang L; Jin C; Li M; Ye L
Int J Clin Exp Pathol; 2015; 8(2):1768-75. PubMed ID: 25973066
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of REDD1 Sensitizes Bladder Urothelial Carcinoma to Paclitaxel by Inhibiting Autophagy.
Zeng Q; Liu J; Cao P; Li J; Liu X; Fan X; Liu L; Cheng Y; Xiong W; Li J; Bo H; Zhu Y; Yang F; Hu J; Zhou M; Zhou Y; Zou Q; Zhou J; Cao K
Clin Cancer Res; 2018 Jan; 24(2):445-459. PubMed ID: 29084921
[No Abstract] [Full Text] [Related]
10. Reduction of Tat-interacting Protein 30 Expression Could be a Prognostic Marker in Bladder Urothelial Cancer.
Li YP; Zhu JF; Huang KT; Wang RR; Cai B; Xie H; Chen HD
Chin Med J (Engl); 2018 Jan; 131(2):188-193. PubMed ID: 29336367
[TBL] [Abstract][Full Text] [Related]
11. Overexpression and clinicopathological contribution of DcR3 in bladder urothelial carcinoma tissues.
Jiang YQ; Zhong TF; Dang YW; Zou LS; Yang L; Yang X; Chen G
Asian Pac J Cancer Prev; 2014; 15(21):9137-42. PubMed ID: 25422191
[TBL] [Abstract][Full Text] [Related]
12. Suppression of Cellular Proliferation and Invasion by HMGB1 Knockdown in Bladder Urothelial Carcinoma Cells.
Liao H; Xiao Y; Hu Y; Xiao Y; Yin Z; Liu L
Oncol Res; 2014; 22(5-6):235-45. PubMed ID: 26629935
[TBL] [Abstract][Full Text] [Related]
13. SLC12A5 interacts and enhances SOX18 activity to promote bladder urothelial carcinoma progression via upregulating MMP7.
Wang L; Zhang Q; Wu P; Xiang W; Xie D; Wang N; Deng M; Cao K; Zeng H; Xu Z; Xiaoming Liu ; He L; Long Z; Tan J; Wang J; Liu B; Liu J
Cancer Sci; 2020 Jul; 111(7):2349-2360. PubMed ID: 32449280
[TBL] [Abstract][Full Text] [Related]
14. DDR2 overexpression in urothelial carcinoma indicates an unfavorable prognosis: a large cohort study.
Tsai MC; Li WM; Huang CN; Ke HL; Li CC; Yeh HC; Chan TC; Liang PI; Yeh BW; Wu WJ; Lim SW; Li CF
Oncotarget; 2016 Nov; 7(48):78918-78931. PubMed ID: 27793038
[TBL] [Abstract][Full Text] [Related]
15. The tumor-suppressor gene Nkx2.8 suppresses bladder cancer proliferation through upregulation of FOXO3a and inhibition of the MEK/ERK signaling pathway.
Yu C; Zhang Z; Liao W; Zhao X; Liu L; Wu Y; Liu Z; Li Y; Zhong Y; Chen K; Li J; Zhou F; Song L
Carcinogenesis; 2012 Mar; 33(3):678-86. PubMed ID: 22223847
[TBL] [Abstract][Full Text] [Related]
16. The ERH gene regulates migration and invasion in 5637 and T24 bladder cancer cells.
Pang K; Zhang Z; Hao L; Shi Z; Chen B; Zang G; Dong Y; Li R; Liu Y; Wang J; Zhang J; Cai L; Han X; Han C
BMC Cancer; 2019 Mar; 19(1):225. PubMed ID: 30866868
[TBL] [Abstract][Full Text] [Related]
17. Dual role of TGFBR3 in bladder cancer.
Liu XL; Xiao K; Xue B; Yang D; Lei Z; Shan Y; Zhang HT
Oncol Rep; 2013 Sep; 30(3):1301-8. PubMed ID: 23835618
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-106a suppresses proliferation, migration, and invasion of bladder cancer cells by modulating MAPK signaling, cell cycle regulators, and Ets-1-mediated MMP-2 expression.
Shin SS; Park SS; Hwang B; Kim WT; Choi YH; Kim WJ; Moon SK
Oncol Rep; 2016 Oct; 36(4):2421-9. PubMed ID: 27513725
[TBL] [Abstract][Full Text] [Related]
19. Derlin-1 overexpression confers poor prognosis in muscle invasive bladder cancer and contributes to chemoresistance and invasion through PI3K/AKT and ERK/MMP signaling.
Dong Q; Fu L; Zhao Y; Tan S; Wang E
Oncotarget; 2017 Mar; 8(10):17059-17069. PubMed ID: 28178653
[TBL] [Abstract][Full Text] [Related]
20. Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway.
Cao R; Meng Z; Liu T; Wang G; Qian G; Cao T; Guan X; Dan H; Xiao Y; Wang X
Oncotarget; 2016 Nov; 7(45):72941-72960. PubMed ID: 27662662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
